Encourages Administration to Reject Measure That Would Increase Premiums on Medicare Part D Beneficiaries, Cost Taxpayers Billions and Boost Profits for Drug Companies Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a television and digital advertising campaign Tuesday against the proposed Rebate Rule in Washington, D.C. and eight key U.S. Senate and […]
Administration Should Withdraw Big Pharma-Backed Policies Like the Rebate Rule, Move Forward with Solutions to Stop Drug Companies’ Price Gouging Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Monday after Big Pharma scuttled a scheduled meeting on prescription drug prices between White House officials and executives representing major pharmaceutical companies. […]
Administration Should Abandon Previously Rejected Measure That Rewards Drug Companies’ Pandemic Price Hikes and 340B Changes That Would Undermine Critical Program for Many of America’s Most Vulnerable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday after the President signed an executive memorandum instructing the U.S. Department of Health and […]
HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and Conservative Commentators Raised Doubts on Premium Increases, Cost to Taxpayers and Bailout for Big Pharma Reports this week indicate the administration may reboot a policy known as the Rebate Rule. The Rebate Rule was previously withdrawn by the White House amid concerns, on both sides of the […]
Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Prices New earnings reports for the second quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug company Novartis announced it bested earnings forecasts for the second quarter after hiking prices […]
Policymakers Should Focus On Market-Based Solutions To Hold Drug Companies Accountable As The Pharmaceutical Industry Continues to Hike Prescription Drug Prices Through the Pandemic BIG PHARMA’S PRICE HIKES CREATED A CRISIS OF AFFORDABILITY Prescription drug prices are out-of-control thanks to the anti-competitive tactics and price-gouging practices of Big Pharma. Despite an escalating crisis of […]
Drug Companies Begin Summer Price Increases With Hikes On 42 Brand Name Drugs Despite Rising Public Concern With Rx Affordability, Opposition to Price Increases Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday after Big Pharma began hiking prescription drug prices in July while Americans continue to grapple with the […]
Survey Finds 83 Percent of Americans Believe Drug Companies Should Stop Price Increases, Majority More Concerned About Rx Prices as a Result of COVID-19 Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday on a new national survey, commissioned by CSRxP and conducted by Morning Consult, that found an overwhelming […]
New Poll Underscores Need for Big Pharma to Suspend Summer Price Hikes and for Policymakers to Advance Market-Based Rx Pricing Solutions Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday after Gallup and West Health released a new poll that found nearly nine in 10 Americans are concerned Big Pharma […]
Lawmakers Must Step-in to Enact DTC List Price Disclosures, Additional Measures to Shine a Light on Big Pharma’s Pricing Practices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday after the U.S. Court of Appeals for the District of Columbia Circuit upheld a ruling blocking the implementation of a measure […]